Brainsway Ltd. (BWAY) –
-
BrainsWay to Report First Quarter 2024 Financial Results on May 8, 2024
-
Brainsway (BWAY) Expands Deep TMS Access in Israel Following Significant Increase in Reimbursement Rates
-
Form 6-K Brainsway Ltd. For: Apr 17
-
BrainsWay Expands Deep TMS™ Access in Israel Following Significant Increase in Reimbursement Rates
-
BrainsWay Announces Published Review Results Highlighting Potential of Deep TMS™ to Treat Parkinson's Disease
-
Form 6-K Brainsway Ltd. For: Apr 04
-
Form 20-F Brainsway Ltd. For: Dec 31
-
BrainsWay Announces Positive Results in Late-Life Depression Post-Marketing Analysis
-
BrainsWay Broadens Partnership with Katie’s Way Plus Through Order of an Additional 18 Deep TMS™ Systems
-
Form 6-K Brainsway Ltd. For: Mar 18
-
Brainsway (BWAY) PT Raised to $13 at H.C. Wainwright
-
Brainsway (BWAY) PT Raised to $10 at Oppenheimer
-
BrainsWay Ltd. (BWAY) Tops Q4 EPS by 1c ; Offers Guidance
-
Form 6-K Brainsway Ltd. For: Mar 06
-
BrainsWay Reports Fourth Quarter and Full-Year 2023 Financial Results and Operational Highlights
-
BrainsWay to Report Fourth Quarter and Full Year 2023 Financial Results on March 6, 2024
-
Form SC 13G/A Brainsway Ltd. Filed by: HIRSCHMAN ORIN
-
Form SC 13G/A Brainsway Ltd. Filed by: RTW INVESTMENTS, LP
-
Form SC 13G/A Brainsway Ltd. Filed by: HIRSCHMAN ORIN
-
BrainsWay Initiates Clinical Evaluation of Rotational Field “Deep TMS 360°™” Technology
-
Form 6-K Brainsway Ltd. For: Jan 10
-
BrainsWay Highlights Expanded Deep TMS™ Access with Growing Western U.S. Network
-
Form 6-K Brainsway Ltd. For: Dec 19
-
BrainsWay Announces Continued Expansion of Deep TMS™ in South Korea
-
Form 6-K Brainsway Ltd. For: Nov 20
-
Louisiana Insurer Expands Deep TMS™ Access for 1.9 Million Covered Lives
-
Brainsway (BWAY) PT Raised to $6 at Oppenheimer
-
Raymond James Downgrades Brainsway (BWAY) to Market Perform
-
Form 6-K Brainsway Ltd. For: Nov 15
-
BrainsWay Ltd. (BWAY) Tops Q3 EPS by 3c
-
BrainsWay Reports Third Quarter 2023 Financial Results and Operational Highlights
-
Form 6-K Brainsway Ltd. For: Nov 02
-
Clinical TMS Society Publishes First Coverage Recommendations for the Treatment of Smoking Addiction
-
BrainsWay to Report Third Quarter 2023 Financial Results on November 15, 2023
-
Brainsway (BWAY) Announces Publication of Study Data on Accelerated Deep Transcranial Magnetic Stimulation for Depression
-
Form 6-K Brainsway Ltd. For: Oct 16
-
BrainsWay Announces Publication of Study Data on Accelerated Deep Transcranial Magnetic Stimulation (Deep TMS™) for Depression
-
BrainsWay Announces Presentation of Two Deep TMS™ Posters at Upcoming World Congress of Psychiatry
-
BrainsWay Broadens Access to Deep TMS™ for U.S. Military Service Members Through Expanded Partnership with Katie’s Way Plus
-
Form 6-K Brainsway Ltd. For: Sep 20
-
Brainsway (BWAY) Enters Partnership with Treatment Provider in Northeast U.S.
-
Form 6-K Brainsway Ltd. For: Sep 05
-
BrainsWay Forges Strategic Partnership with Treatment Provider in Northeast U.S.
-
Form 6-K Brainsway Ltd. For: Aug 23
-
BrainsWay Further Expands Access to Deep TMS™ in Asia Pacific Region
-
Brainsway (BWAY) PT Raised to $5.50 at Northland Capital Markets
-
BrainsWay Ltd. (BWAY) Tops Q2 EPS by 3c
-
Form 6-K Brainsway Ltd. For: Aug 09
-
BrainsWay Reports Second Quarter 2023 Financial Results and Operational Highlights
-
Brainsway Ltd. (BWAY) Announces Publication of Three New Deep TMS Research Publications
Back to BWAY Stock Lookup